Kevin Coleman Jr.
Story Poster
Post Game Review: No. 14 Texas A&M 34, Mississippi State 24
28 days ago by Kay Naegeli
Defensive miscues allowed Mississippi State to stay neck-and-neck with No. 14 Texas A&M before the Aggies pulled away permanently in the third quarter for their sixth consecutive win. In his first year, Mike Elko has now led A&M to a 4-0 SEC start for the first time since 2016.
Story Poster
Moss, No. 14 Ags look to pick up where they left off vs. Mississippi State
1 mo ago by Olin Buchanan
The bye week has come and gone, and now, the 14th-ranked Texas A&M Aggies hope to keep their winning ways rolling when they face Mississippi State at 3:15 p.m. CT on Saturday. Behind the rushing attack of Le'Veon Moss, A&M has rattled off five straight victories.
Story Poster
Key Matchups: No. 14 Texas A&M at Mississippi State
1 mo ago by Olin Buchanan
On paper, 14th-ranked Texas A&M appears to have the upper hand on 1-5 Mississippi State, but Saturdays in the SEC are always a battle. With the Aggies looking to end their nightmares in Starkville, Olin Buchanan details the in-game matchups he is keeping an eye on in Week 8.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
9:40
Nuño's Notes: Status of Lebby's Bulldogs as A&M goes to Starkville
1 mo ago by David Nuño
Get ready for more cowbell as No. 14 Texas A&M takes its five-game winning streak to Mississippi State in Week 8. After speaking to a number of insiders from StarkVegas, David Nuño shares what he has gathered about the 1-5 Mississippi State Bulldogs.
Story Poster
Players to Watch: No. 14 Texas A&M at Mississippi State
1 mo ago by Olin Buchanan
A sixth consecutive victory is in reach as 14th-ranked Texas A&M heads to Starkville looking to garner more momentum in the midst of Southeastern Conference play. Ahead of the bout, Olin Buchanan identifies players from both the Aggies and Bulldogs to keep an eye on.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.